DXC Technology’s third quarter saw sales decline year-over-year, though the market responded positively to the results. Management attributed the period’s mixed performance to continued pressure in ...
Welcome back. I’m Matt Bird your host. We are coming off another panel and I’ve got with me next the chief medical officer for DXC Technologies of North America, George Mathew. George, how are you ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback